Rankings: Managing IP's Rising Stars 2020 The 2020 edition of Managing IP’s Rising Stars publication is now available online By Kingsley Egbuonu October 19 2020
Mylan injunction provides new weapon against ‘patent abuse’ Mylan’s injunction against Teva gives generics companies a new tool to combat last-minute revocations of parent patents at the EPO By Charlotte Kilpatrick October 15 2020
Generics say French Eli Lilly decision not worth its salt European in-house counsel say the ‘dangerous’ ruling will delay the launch of generic products and create legal uncertainty By Charlotte Kilpatrick September 23 2020
The research for IP STARS and MIP Awards (2021 edition) Research is underway for the 2021 edition of the IP STARS rankings and Managing IP Awards programme By Kingsley Egbuonu September 18 2020
Opinion: It won’t be courts that drive virtual litigation Citizens rather than courts are more likely to shape the future of virtual litigation, despite the success of remote trials By Ed Conlon September 17 2020
GI protection ‘subsidiary concern’ in EU trade talks With Brexit looming, UK food and spirit producers say losing geographical indication protection is less of a threat than increased tariffs into the EU By Charlotte Kilpatrick September 17 2020
This week in IP: MF Brands interview, Apple, Cisco sue USPTO, AG copyright opinion Managing IP rounds up the latest trademark, copyright and patent news, including some stories you might have missed By Ed Conlon & Max Walters September 04 2020
The Trueman flow: why timing is everything in biosimilars Neil Trueman, chief international IP counsel at Mundipharma and corporate IP Star, delves into the IP challenges of biosimilar and generics manufacturing By Charlotte Kilpatrick August 27 2020
